Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Biomarker Clinical Phase Outsourcing Services Market

Biomarker Clinical Phase Outsourcing Services Market Share

Report ID: GMI7610
Published Date: Dec 2023
Report Format: PDF

Download Free Sample

Biomarker Clinical Phase Outsourcing Services Market Share

The market is characterized by diverse players competing in the healthcare industry. Laboratory Corporation of America Holdings, Parexel International Corporation, and Charles River Laboratories International, Inc., account for significant market share. These prominent players thrive through a combination of strategic initiatives, investing in research and development, meeting the specific needs of patients, geographical expansion, strategic approaches, product diversification, and regulatory compliance.

Biomarker Clinical Phase Outsourcing Services Market Companies

Foremost players operating in the biomarker clinical phase outsourcing services industry is as mentioned below:

Laboratory Corporation of America Holdings
Parexel International Corporation
Charles River Laboratories International, Inc.
ICON plc
Proteome Sciences plc
Fujirebio Inc
WuXi AppTec Co., Ltd.
NorthEast BioAnalytical Laboratories LLC.
Celerion, Inc.
GenScript ProBio Co., Ltd.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Biomarker clinical phase outsourcing services industry size was around USD 7.9 billion in 2023 and is expected to reach USD 38.9 billion by end of 2032 driven by rapid advancements in biomarker technology, and the rising government initiatives and funding.

The surrogate endpoints segment held the 54.6% of the market share in 2023 and is expected to grow at a lucrative pace by 2032, driven by the growing demand for precision medicines and the rise in the number of clinical trials.

North America held 42.1% of the biomarker clinical phase outsourcing services industry share in 2023 and is anticipated to expand at a significant pace from 2024-2032 driven by advanced healthcare infrastructure, including state-of-the-art research facilities and laboratories.

Laboratory Corporation of America Holdings, Parexel International Corporation, Charles River Laboratories International, Inc., and ICON plc are some of the major industry contenders.